Brokerages Set Pediatrix Medical Group, Inc. (NYSE:MD) PT at $17.08

Shares of Pediatrix Medical Group, Inc. (NYSE:MD - Get Free Report) have earned an average rating of "Hold" from the six ratings firms that are covering the stock, Marketbeat.com reports. Four research analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 12 month price objective among brokerages that have issued a report on the stock in the last year is $16.75.

A number of analysts recently commented on the stock. Macquarie assumed coverage on shares of Pediatrix Medical Group in a research note on Monday, December 16th. They set an "outperform" rating and a $18.00 price target on the stock. StockNews.com upgraded Pediatrix Medical Group from a "hold" rating to a "buy" rating in a research note on Wednesday, January 22nd. UBS Group lifted their target price on Pediatrix Medical Group from $16.50 to $18.50 and gave the company a "neutral" rating in a report on Friday, February 21st. Finally, Truist Financial lowered their price target on shares of Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating on the stock in a report on Friday.

Pediatrix Medical Group Stock Performance

Shares of MD traded down $0.09 during mid-day trading on Thursday, hitting $13.32. The stock had a trading volume of 383,617 shares, compared to its average volume of 839,328. Pediatrix Medical Group has a 52 week low of $6.62 and a 52 week high of $17.67. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.60 and a quick ratio of 1.42. The business has a fifty day moving average price of $14.31 and a 200-day moving average price of $13.94. The firm has a market cap of $1.14 billion, a P/E ratio of -11.10, a PEG ratio of 1.74 and a beta of 1.32.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last announced its quarterly earnings data on Thursday, February 20th. The company reported $0.49 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.37 by $0.12. The business had revenue of $502.36 million for the quarter, compared to analysts' expectations of $486.22 million. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. On average, equities research analysts expect that Pediatrix Medical Group will post 1.38 EPS for the current year.

Institutional Trading of Pediatrix Medical Group

Several institutional investors and hedge funds have recently modified their holdings of the business. Pacer Advisors Inc. bought a new position in shares of Pediatrix Medical Group in the fourth quarter worth approximately $35,492,000. American Century Companies Inc. increased its holdings in shares of Pediatrix Medical Group by 628.2% in the 4th quarter. American Century Companies Inc. now owns 1,739,323 shares of the company's stock worth $22,820,000 after buying an additional 1,500,485 shares during the last quarter. Oberweis Asset Management Inc. purchased a new stake in shares of Pediatrix Medical Group during the 4th quarter valued at $6,122,000. Renaissance Technologies LLC lifted its holdings in shares of Pediatrix Medical Group by 117.4% during the 4th quarter. Renaissance Technologies LLC now owns 838,800 shares of the company's stock worth $11,005,000 after acquiring an additional 453,000 shares during the last quarter. Finally, Boston Partners grew its position in Pediatrix Medical Group by 25.2% in the fourth quarter. Boston Partners now owns 1,956,353 shares of the company's stock worth $25,922,000 after acquiring an additional 393,600 shares in the last quarter. Hedge funds and other institutional investors own 97.71% of the company's stock.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.